Arcoma AB (ARCOMA.ST)

SEK 10.95

(3.3%)

Net Debt Summary of Arcoma AB

  • Arcoma AB's latest annual net debt in 2023 was -1.12 Million SEK , down -107.31% from previous year.
  • Arcoma AB's latest quarterly net debt in 2024 Q3 was -10.68 Million SEK , down -74.03% from previous quarter.
  • Arcoma AB reported annual net debt of 15.43 Million SEK in 2022, up 31.02% from previous year.
  • Arcoma AB reported annual net debt of 11.77 Million SEK in 2021, up 39.81% from previous year.
  • Arcoma AB reported quarterly net debt of -4.48 Million SEK for 2024 Q1, down -297.78% from previous quarter.
  • Arcoma AB reported quarterly net debt of -6.14 Million SEK for 2024 Q2, down -36.88% from previous quarter.

Annual Net Debt Chart of Arcoma AB (2023 - 2012)

Historical Annual Net Debt of Arcoma AB (2023 - 2012)

Year Net Debt Net Debt Growth
2023 -1.12 Million SEK -107.31%
2022 15.43 Million SEK 31.02%
2021 11.77 Million SEK 39.81%
2020 8.42 Million SEK 66.15%
2019 5.07 Million SEK -8.47%
2018 5.53 Million SEK 308.39%
2017 -2.65 Million SEK -123.86%
2016 11.13 Million SEK 88.13%
2015 5.92 Million SEK -51.36%
2014 12.17 Million SEK -47.5%
2013 23.18 Million SEK 114.71%
2012 10.79 Million SEK 0.0%

Peer Net Debt Comparison of Arcoma AB

Name Net Debt Net Debt Difference
Acarix AB (publ) -35.14 Million SEK 96.791%
ADDvise Group AB (publ) 1.22 Billion SEK 100.092%
ADDvise Group AB (publ) 1.22 Billion SEK 100.092%
Bactiguard Holding AB (publ) 109.88 Million SEK 101.027%
BICO Group AB (publ) 927.9 Million SEK 100.122%
Boule Diagnostics AB (publ) 128.8 Million SEK 100.876%
CellaVision AB (publ) -56.94 Million SEK 98.019%
Clinical Laserthermia Systems AB (publ) -14.87 Million SEK 92.418%
Chordate Medical Holding AB (publ) -8.45 Million SEK 86.659%
C-Rad AB (publ) -127.6 Million SEK 99.116%
Duearity AB (publ) 10.23 Million SEK 111.025%
Dignitana AB (publ) 13.07 Million SEK 108.626%
Episurf Medical AB (publ) -52.7 Million SEK 97.86%
Getinge AB (publ) 5.4 Billion SEK 100.021%
Scandinavian Real Heart AB (Publ) -35.05 Million SEK 96.782%
Iconovo AB (publ) -10.75 Million SEK 89.512%
Integrum AB (publ) -10.47 Million SEK 89.233%
Luxbright AB (publ) -13.83 Million SEK 91.846%
Mentice AB (publ) -49.56 Million SEK 97.724%
OssDsign AB (publ) -162.78 Million SEK 99.307%
Paxman AB (publ) -11.41 Million SEK 90.115%
Promimic AB (publ) -50.32 Million SEK 97.758%
Qlife Holding AB (publ) 19.07 Million SEK 105.915%
SciBase Holding AB (publ) -27.32 Million SEK 95.872%
ScandiDos AB (publ) -1.53 Million SEK 26.323%
Sectra AB (publ) -772.85 Million SEK 99.854%
Sedana Medical AB (publ) -226.87 Million SEK 99.503%
Senzime AB (publ) -139.54 Million SEK 99.192%
SpectraCure AB (publ) -50.23 Million SEK 97.755%
Stille AB -178.5 Million SEK 99.368%
Vitrolife AB (publ) 1.22 Billion SEK 100.092%
Xvivo Perfusion AB (publ) -214.65 Million SEK 99.474%